A structural brain lesion is detectable on MRI in approximately 65% of people with epilepsy.^[@R1]^ In temporal lobe epilepsy (TLE), the most common pathology is hippocampal sclerosis (HS),^[@R2]^ with the study of HS-TLE informing TLE\'s archetypal neuropsychological profile of anterograde memory impairment.^[@R3]^ This led to an inference that memory disturbance in TLE is the result of structural compromise due to "nonfunctional" tissue.^[@R4][@R5][@R6]^

Growing evidence, however, indicates that memory deficits in TLE can occur on a background of diffuse cognitive disturbances that implicate regions beyond the epileptogenic zone.^[@R7]^ This fits with our evolving understanding of epilepsy as a disease that propagates and alters large-scale networks subserving cognitive and emotional processing,^[@R8]^ whereby any etiology that results in epileptogenic disease may undermine neuropsychological function.^[@R9][@R10][@R11]^ This conceptual shift questions the specific effects of a lesion on neuropsychological functioning in TLE, as opposed to the effects of underlying network disease common to all cases. To date, studies comparing memory in MRI-negative TLE to lesional cases have been low-powered,^[@R5],[@R12]^ failed to provide appropriate comparison groups,^[@R12]^ and report mixed findings.^[@R5],[@R13],[@R14]^

We aimed to prospectively clarify the contribution of macroscopic structural compromise to neuropsychological dysfunction in TLE. We hypothesized that patients with MRI-negative TLE will perform worse than controls on measures of memory and mood. The cumulative effect of a lesion occurring in addition to network disease, however, will give rise to even greater neuropsychological impairment; i.e., HS-TLE and MRI-positive TLE will perform worse than MRI-negative cases. Finally, we delineate predictors of neuropsychological dysfunction in these groups.

Methods {#s1}
=======

Participants {#s1-1}
------------

Inclusion criteria for all participants (n = 152) were (1) age 18--70 y, (2) Full-Scale IQ (FSIQ) score ≥70 or FSIQ judged to be unimpaired via formal neuropsychological assessment, (3) no history of neurosurgery, and (4) functional English. FSIQ was estimated using the Test of Premorbid Functioning.^[@R15]^ Inclusion criteria related to FSIQ pertain to the standard ethics approvals granted to this study, in which adults with a known or likely intellectual disability are deemed unable to give independent informed consent to participate in research. Moreover, the validity of the measures of memory and mood administered to the sample depends on the participants\' ability to read and comprehend self-report measures, recognize and convey abstract mood symptomatology, as well as follow complex task instructions. The variability of persons with intellectual disability to conform to these standards was seen to introduce an unacceptable level of confound to study design.^[@R16]^

Exclusion criteria for patients comprised a history of neurologic disease other than epilepsy, and psychiatric diagnoses other than depressive or anxiety disorders. Exclusion criteria for the controls comprised any history of neurologic disease or major psychiatric illness.

Standard protocol approvals, registrations, and patient consents {#s1-2}
----------------------------------------------------------------

In accordance with the Declaration of Helsinki, this study was approved by the relevant institutional human research ethics committees, and all participants provided written, informed consent.

Patients {#s1-3}
--------

The patient sample (n = 79) was prospectively recruited from the Comprehensive Epilepsy Program of Austin Health, Melbourne. Epileptogenic foci were localized to the temporal lobe by methods previously published by our group,^[@R17]^ including clinical history, semiology, video-EEG, 3-tesla MRI, interictal \[^18^F\] fluorodeoxyglucose--PET, ictal SPECT, and neuropsychological evaluation. Demographic and clinical features of the TLE sample are summarized in [table 1](#T1){ref-type="table"}. The proximity of the last seizure to neuropsychological testing was not routinely recorded.

###### 

Demographic and clinical profile of temporal lobe epilepsy subgroups and healthy controls
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Nineteen patients (24%) had a focal lesion detectable on clinical MRI consistent with HS-TLE, 30 (38%) had a focal lesion confined to the temporal lobe judged to be an epileptogenic pathology other than HS (MRI-pos TLE), and 30 (38%) did not have any focal lesion detectable on MRI (MRI-neg TLE; [table 1](#T1){ref-type="table"}). Key subgroup clinical findings were:HS-TLEmore likely to have had febrile convulsions (42%) relative to MRI-pos (17%) and MRI-neg TLE (7%; χ^2^~2~ = 9.67, *p* = 0.008, ϕ = 0.35, medium effect size \[ES\]);more likely to have experienced status epilepticus (16%) relative to MRI-pos (3%) and MRI-neg TLE (0%; χ^2^~2~ = 6.21, *p* = 0.045, ϕ = 0.28, medium ES);more likely to have had encephalitis (11%) relative to MRI-pos and MRI-neg TLE, none of whom had had it (χ^2^~2~ = 6.48, *p* = 0.039, ϕ = 0.29, medium ES).MRI-neg TLEless likely to be deemed surgical candidates (13%) compared to HS-TLE (74%) and MRI-pos TLE (90%; χ^2^~2~ = 35.60, *p* \< 0.001, ϕ = 0.69, large ES\];less likely to have a concordant PET abnormality (64%) vs HS-TLE (100%) and MRI-pos TLE (92%; χ^2^~2~ = 10.94, *p* = 0.004, ϕ = 0.41, medium to large ES); unlike in previous studies, \[^18^F\] fluorodeoxyglucose--PET concordance encompassed focalization to the temporal lobe in addition to the putative laterality and might account for the lower rates of PET concordance in MRI-negative compared to previous studies^[@R12]^;when PET-concordant, did not differ from those who did not have a concordant PET abnormality in terms of epileptologic features, such as age at onset, seizure frequency, and lateralization (*p* \< 0.05 for all comparisons).

Healthy controls {#s1-4}
----------------

Seventy-three healthy individuals were recruited from the patients\' families and broader community to provide a sociodemographically matched control sample of similar size to the patient sample. Patients and controls did not differ in sex (χ^2^ = 3.40, *p* = 0.065), age (*t*~137,33~ = 1.76, *p* = 0.081), or years of education (*t*~150~ = −8.15, *p* = 0.42; [table 1](#T1){ref-type="table"}). Controls had a slightly higher FSIQ than the patients overall (*t*~148~ = −2.51, *p* = 0.013, η^2^ = 0.04, small ES); however, mean scores for both groups fell within the "average" range (90--110).

Assessments {#s1-5}
-----------

### Neuropsychiatric evaluation {#s1-5-1}

In-depth neuropsychiatric evaluation of patients was undertaken using the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID), the gold standard for diagnosing mood disturbance according to the criteria of the DSM-IV.^[@R18]^ The SCID includes questioning around atypical symptoms of depression some researchers consider to be of especial relevance to epilepsy.^[@R19]^ Patients were carefully questioned about depressive symptoms to ensure they could not be directly attributed to changes in antiepileptic medication.

The Neurological Disorders Depression Inventory for Epilepsy (NDDI-E)^[@R20]^ assesses the frequency of 6 current depressive symptoms, which do not overlap with commonly comorbid cognitive deficits in epilepsy or the adverse effects of antiepileptic drugs. NDDI-E total scores range from 6 to 28; scores \>15 have 90% specificity and 81% sensitivity for a diagnosis of major depression.

The Patient Health Questionnaire--Generalized Anxiety Disorder 7-item (PHQ-GAD-7) assesses the severity of 7 current anxiety symptoms in medical populations.^[@R21]^ Participants assign scores of 0 to 3 to the response categories of "not at all" through to "nearly every day"; total scores range from 0 to 21, and scores of 5, 10, and 15 represent cutoffs for mild, moderate, and severe anxiety, respectively.

### Memory assessment {#s1-5-2}

The Autobiographical Memory Interview (AMI)^[@R22]^ assesses recall of personal memories from childhood, early adulthood, and recent life. The Personal Semantic Schedule requires participants to recollect personally relevant facts across the 3 time points (e.g., former addresses; maximum score = 63), with scores ≤47 associated with an amnestic syndrome and 48 or 49 a probable amnestic syndrome. The Autobiographical Incidents Schedule asks participants to recall 3 episodes from each time period (e.g., a wedding ceremony). Episodic memories are scored from 0 to 3 (maximum = 27) based on their richness in detail and how precisely the incident is located in place and time, with total scores ≤12 associated with an amnestic syndrome, and 13 to 15 a probable amnestic syndrome. Interrater reliability is *r* = 0.83--0.86, with good sensitivity to organic disease.

Auditory-verbal memory was assessed using the Wechsler Memory Scale--Fourth Edition^[@R23]^---specifically, immediate and delayed recall indices of the Verbal Paired Associates (VPA) subtest. The examiner presents a list of 14 word pairs; the participant then hears one word and must provide the word that went with it. Some pairs are semantically related (e.g., "street-road"), considered an indicator of lateral temporal lobe integrity; others are arbitrarily associated (e.g., "bed-lost"), considered an indicator of mesial temporal lobe integrity.^[@R3],[@R23],[@R24]^ There are 4 learning trials and one delayed recall trial, scored according to age-scaled normative data (mean = 10; SD = 3); i.e., scaled scores \<8 are indicative of below-average performance.

The delay trial of the Rey-Osterrieth Complex Figure (ROCF) is a widely used test of figural memory retrieval.^[@R25]^ The participant must copy the figure, reproducing it from memory 30 minutes later. The figure was scored according to the system proposed by Osterrieth that reduces it to 18 details that are scored 2, 1, or 0.5 (maximum score = 36). It has high inter- and intrarater reliability (\>0.8) and internal consistency (\>0.6).

Data availability {#s1-6}
-----------------

Anonymized data will be shared by request from any qualified investigator.

Statistical analyses {#s1-7}
--------------------

Analyses were performed using IBM SPSS Statistics (IBM Corp., Armonk, NY) and R (R Foundation for Statistical Computing, Vienna, Austria). The Benjamini-Hochberg procedure was used throughout to control the false discovery rate stemming from multiple comparisons,^[@R26]^ with significance set at *p* \< 0.05 (2-tailed). Where data did not meet assumptions for parametric analyses, conservative alternatives were used (e.g., Mann-Whitney *U*, Brown-Forsythe). Some control data were missing because of a change in protocol, so Little\'s missing completely at random test was used on a subset of cases and showed that there was no relationship between the missingness of data and any values (χ^2^~2~ = 4.212, *p* \> 0.050). Very minimal patient data were missing and typically occurred because of interruptions in testing by seizures or early discharge. Given the difference in FSIQ between patients and controls, scatterplots and Pearson correlations were used to assess the relationships between memory indices and FSIQ in these 2 groups; no significant relationships were identified (*r* \< 0.3), negating the need to covary for FSIQ in subsequent analyses.

To test the hypothesis that the neuropsychological performances in the MRI-neg TLE group would be worse than those of controls, their memory and mood scores were compared using χ^2^ analyses for categorical variables and independent-sample *t* tests for continuous variables (illustrated by the [figure](#F1){ref-type="fig"}).

![Equivalent memory and mood dysfunction across TLE subtypes\
Relative to controls, patients with MRI-neg TLE showed significantly impaired autobiographical, verbal, and visual memory (A), as well as significantly more symptoms of depression and anxiety (B). Contrary to expectations, the 3 TLE subgroups showed no significant differences in memory (A) or mood (B). These boxplots represent *z* scores calculated from the healthy control raw data. Purple shading and asterisks delineate comparisons between the MRI-neg TLE group and healthy controls, while green boxes delineate comparisons between the 3 TLE groups (no significant differences on any measure). \**p* \< 0.05; \*\**p* \< 0.01; \*\*\**p* \< 0.001. AMI = Autobiographical Memory Interview; HS-TLE = temporal lobe epilepsy with hippocampal sclerosis; MRI-neg TLE = MRI-negative temporal lobe epilepsy; MRI-pos TLE = MRI-positive temporal lobe epilepsy; NDDI-E = Neurological Disorders Depression Inventory for Epilepsy; PHQ-GAD-7 = Patient Health Questionnaire--Generalized Anxiety Disorder 7-item; RCF = Rey Complex Figure; VPA = Verbal Paired Associates.](NEUROLOGY2018901215FF1){#F1}

To test the hypothesis that patients with either HS-TLE or MRI-pos TLE would score worse than patients with MRI-neg TLE on measures of mood and memory, 1-way between-subjects analysis of variance with planned contrasts were used (illustrated by the [figure](#F1){ref-type="fig"}). The effect of seizure laterality on neuropsychological functioning in the 3 TLE groups was assessed with nonparametric statistics and was found to be nonsignificant (*p* \> 0.05), discounting the need for covariance in subsequent analyses.

Finally, exploratory analyses examined the differential predictors of memory dysfunction in TLE subgroups using analysis of covariance (ANCOVA). The number of outcome variables was reduced by selecting one from each domain (autobiographical, verbal, visual memory), choosing the variable with the largest ES when comparing MRI-neg TLE to controls: that is, AMI episodic recall, VPA-II, and ROCF delayed recall. The ANCOVA models were used to examine predictors of dysfunction separately for each domain, while accounting for lesion status (3 levels: MRI-neg, MRI-pos, HS-TLE). The relative importance of all epilepsy, demographic, and mood predictors (i.e., all those detailed in [tables 1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}) to these 3 outcome variables was examined as follows: in the case of categorical predictors (e.g., sex), the strength of their relationship with an outcome variable was assessed via analysis of variance or *t* tests; for linear variables (e.g., seizure frequency), bivariate correlations. Only independent variables that were significantly associated with the outcome variable were then entered into an ANCOVA model containing the grouping variable "TLE-type." The "step" function in R was used to select the best-fitting model.

###### 

Neuropsychological dysfunction in MRI-neg TLE relative to healthy controls (n = 91)

![](NEUROLOGY2018901215TT2)

For AMI, the initial model (in R notation) passed to "step" was specified as:where onset = age at onset.

For VPA-II, the initial model was specified as:

For ROCF, the initial model was specified as:where SCID_pastdep = history of depression, as assessed via the SCID.

Significant interactions were followed up with planned contrasts evaluating the significance of the slope parameter (β) relating the independent variable to the outcome variable in the MRI-neg TLE group, and comparing the slope parameter in the MRI-neg TLE group to those in the HS-TLE group and the MRI-pos TLE group.

Results {#s2}
=======

MRI-neg TLE is not neuropsychologically benign {#s2-1}
----------------------------------------------

### MRI-neg TLE is not cognitively benign {#s2-1-1}

As hypothesized, patients with MRI-neg TLE presented with neuropsychological impairment. Relative to controls, they showed impoverished autobiographical, verbal, and visual memory, as well as higher symptoms of depression and anxiety ([table 2](#T2){ref-type="table"} for descriptive data and ES). Specifically, they were poorer at recollecting semantic autobiographical details (*t*~89~ = −2.75, *p* \< 0.01, 95% confidence interval \[CI\] −4.02 to −0.65), episodic autobiographical events (*t*~89~ = −5.22, *p* \< 0.001, 95% CI −7.15 to −3.20), visuospatial information on the ROCF after a delay (*t*~54~ = −2.54, *p* \< 0.05, 95% CI −7.10 to −0.83), and were worse at both immediate recall on VPA-I (*t*~61~ = −3.70, *p* \< 0.001, 95% CI −4.41 to −1.32) and later spontaneous retrieval of word pairs on VPA-II (auditory-verbal memory; *t*~46.09~ = −4.88, *p* \< 0.001, 95% CI −4.11 to −1.71) ([figure](#F1){ref-type="fig"}, A).

Within the MRI-neg group, there was a difference in the episodic autobiographical recollection of those who were PET-positive and those who were not; namely, those who were lesion-negative and PET-negative were poorer at recalling personal life events (*t*~23~ = 2.28, *p* = 0.033, 95% CI 0.37--7.76; Cohen *d* = 0.99, i.e., large ES). There were no differences on any other neuropsychological measure between those with and without a congruent PET (*p* \> 0.05), or any differences based on seizure onset laterality.

### MRI-neg TLE is not psychiatrically benign {#s2-1-2}

People with MRI-neg TLE endorsed higher levels of depressive symptomatology on the NDDI-E than controls (*t*~98~ = 2.84, *p* = 0.005, 95% CI 0.63--3.56), as well as higher levels of anxiety-related symptomatology on the PHQ-GAD-7 (*t*~95~ = 2.42, *p* = 0.017, 95% CI 0.44--4.41; [figure, B](#F1){ref-type="fig"}). In MRI-neg TLE, depression and anxiety symptoms were strongly correlated (*r* = 0.89, *p* \< 0.001).

The SCID revealed that 9 individuals with MRI-neg TLE (30%) met criteria for a current depressive disorder, higher than the global point prevalence of 4.7% (95% CI 4.4%--5.0%^[@R27]^; Fisher exact test, *p* = 0.007). Fifteen patients with MRI-neg TLE (50%) had a lifetime history of, or current, mood disorder, markedly higher than 17% of Australians from the broader community who will experience depression in their lifetime.^[@R28]^ There were no laterality or PET effects on mood evident within MRI-neg TLE (*p* \> 0.05).

Comparable neuropsychological dysfunction in MRI-neg and lesional TLE {#s2-2}
---------------------------------------------------------------------

Contrary to expectations, patients with MRI-neg TLE performed just as poorly as patients with HS-TLE and MRI-pos TLE across all measures of memory; that is, there were no differences in performance for the 3 groups on any of the psychometric measures (*p* \> 0.05; [table 3](#T3){ref-type="table"} and the [figure](#F1){ref-type="fig"}). There were also no laterality effects evident in the scores of the 3 TLE subtypes.

###### 

Comparable neuropsychological dysfunction across temporal lobe epilepsy subtypes^a^
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Similarly, the level of depressive and anxious symptomatology did not differ between groups (*p* \> 0.05; [table 3](#T3){ref-type="table"} and the [figure](#F1){ref-type="fig"}).

Predictors of memory dysfunction in TLE {#s2-3}
---------------------------------------

The final model of predictors of episodic autobiographical retrieval (AMI total score, Autobiographical Incidents Schedule) revealed an interaction between TLE type and age at onset (*F*~2,69~ = 3.51, *p* = 0.035). This interaction reflected better AMI scores with increasing age at onset in the MRI-neg TLE group (β = 0.22, *t* = 2.73, *p* = 0.024), with the slope of this relationship greater in MRI-neg TLE than that in MRI-pos TLE (*t* = −2.25, *p* = 0.028) and HS-TLE (*t* = −2.42, *p* = 0.027).

The final model of predictors of auditory verbal memory (VPA-II) included only FSIQ (*F*~1,61~ = 12.0, *p* = 0.001). VPA-II scaled scores increased with increasing FSIQ (β = 0.12); the influence of FSIQ did not differ between TLE groups.

The final model of predictors of visual recall (ROCF) included TLE type, FSIQ, SCID past depression, and a TLE type × SCID past depression interaction. ROCF scores increased with increasing FSIQ (β = 0.06; *F*~1,58~ = 5.60, *p* = 0.021); the influence of FSIQ did not differ between TLE groups.

Discussion {#s3}
==========

This study confirmed that neuropsychological dysfunction in epilepsy can arise in the context of macroscopically normal brain tissue, with mood and memory significantly impaired in a large sample of patients with MRI-negative TLE relative to healthy controls. That is, a "normal" MRI in epilepsy is not necessarily neuropsychologically benign. Contrary to expectations, moreover, MRI-negative TLE presented with neuropsychological decrements comparable in magnitude to those seen in HS or other MRI-resolvable lesions. This suggests that at the group level, network disease per se is capable of producing memory and affective disturbances as extensive as those produced by overt focal pathology. In MRI-negative disease, neuropsychological impairment was specifically linked to earlier age at seizure onset, while lower FSIQ was revealed as a predictor of poor memory across TLE subtypes. Taken together, the findings suggest that neuropsychological impairments in TLE are not contingent on macroscopic lesions, and in some cases, might be conceptualized as an intrinsic property of an underlying network disease with various etiologies.

In line with previous studies, the current findings demonstrate that people with MRI-negative TLE have impaired memory,^[@R5],[@R13],[@R14]^ including the personally meaningful domain of autobiographical memory. Moreover, MRI-negative TLE is linked to higher rates of depressive disorder and symptomatology than is seen in controls. Neuropsychological compromise occurring in the absence of a resolvable lesion suggests that macroscopic pathology cannot account for every case of impairment in TLE. Moreover, our results indicate that neuropsychological deficits do not necessarily stem from abnormal hypometabolism, a surrogate marker of microstructural abnormalities not seen on MRI. Without histopathologic analysis, the possibility that a minority of the patients with MRI-negative TLE had abnormal microcellular anatomy contributing to their poor memory cannot be ruled out.^[@R5]^ However, it is reasonable to speculate that for the majority of MRI-negative cases, cognitive and affective comorbidities are underpinned by its fundamentally abnormal network function and topography.^[@R29],[@R30]^

The findings extend previous work by revealing that at a group level, neither HS nor any other lesional pathology is more pernicious to memory and mood than nonlesional network disease. Inspection of the psychometric results shows that there is considerable heterogeneity within each TLE subtype, with performances of patients with the same lesion status ranging from intact to markedly impaired. That is, while tissue damage and network disease can undermine neuropsychological function in some cases, in others the diseased brain retains sufficient functional integrity to support normal neuropsychological function or perhaps has reorganized to support it.^[@R4]^ Lesion status cannot, therefore, be used as a heuristic in predicting cognitive or affective dysfunction in TLE; it remains to be ascertained by careful clinical and psychometric examination.^[@R31]^ In particular, the high rates of autobiographical memory impairment across patients suggest that more routine screening of this domain may provide useful insights into the cognitive integrity and subjective complaints of patients with epilepsy than is typically examined.^[@R10],[@R32],[@R33]^

While no laterality effects were evident, verbal ability cannot be assumed to be lateralized to the left hemisphere since it was not directly assessed in these participants (i.e., by fMRI). Another likely limitation of this study was that the verbal memory measure used conflates semantically loaded material with arbitrarily associated material, the latter considered a proximal marker of left mesial temporal lobe disease.^[@R3],[@R24]^ As such, a more sensitive measure of verbal arbitrary binding may have disclosed discrete impairments in patients with left HS-TLE at a higher rate than in right HS or other TLE types, given their homogeneously located foci. An alternative interpretation is that the lack of laterality effects on neuropsychological functioning in this study is a feature of diffuse, bilateral network abnormalities that can occur in both lesion-positive and -negative TLE.^[@R30]^ Future studies should aim to include metrics of wider neuropsychological dysfunction to tease out these potential effects, including measures of language lateralization.

Given that memory and mood disturbances were found to occur in the absence of structural damage, we sought to identify what factors might underpin memory problems in nonlesional disease. Results highlight the multidetermined nature of memory deficits in TLE.

In the first instance, younger age at seizure onset was found to contribute to poor recall of personally relevant memories in MRI-negative TLE, but not lesional TLEs. From a developmental perspective, early seizure onset may disrupt the normal maturation of neural circuits that go on to form a constellation of networks that underpin cognition via physiologic changes such as aberrant sprouting and reduced neurogenesis,^[@R34]^ as well as altered functioning and connectivity that stems from the abnormal coactivation of cognitive networks during epileptogenic discharges.^[@R35],[@R36]^ Consequently, the cognitive networks of patients with early-onset epilepsy seem to develop abnormally, even in the absence of structural pathology.^[@R37]^ Onset of MRI-negative disease in childhood could reasonably accumulate more damage to the function or microscopic integrity of the autobiographical memory network^[@R38]^ than adult-onset disease, producing the memory dysfunction evident in our behavioral testing. Alternatively, frequent seizure activity since childhood could interrupt the consolidation of day-to-day events, with "blank spots" or only vague engrams for autobiographical periods surrounding seizures or other subclinical activity.^[@R36]^ While neither process would be unique to nonlesional disease, its specificity to MRI-neg TLE in this study may fit with the growing notion that nonlesional epilepsy could be a subtly more diffuse disease process than is seen in circumscribed epileptogenic lesions, for reasons that are yet to be elucidated.^[@R39]^

Across both verbal and visual domains of memory, recall impairments in MRI-neg TLE as well as lesional cases were linked to lower general FSIQ. In neurotypical adults, MRI tractography shows that variation in general cognitive ability is related to the integrity of a widely distributed network of white matter involving all cortical lobes of the brain.^[@R40]^ This is consistent with findings in epilepsy that (1) HS-TLE and MRI-neg TLE alike show tract-specific atrophy across dispersed brain regions,^[@R29]^ and (2) memory deficits in this population are associated with altered integrity of white matter tracts.^[@R41]^ It is reasonable to speculate that links between lowered FSIQ and recall problems across subtypes of TLE may be the product of subtle, diffuse changes to white matter organization not typically visualized on clinical MRI. A limitation of the current study, however, is the exclusion of patients with intellectual disability. This is an important subgroup of people with epilepsy who require tailored clinical care and specific representation in research, to ensure the generalizability of neuropsychological findings across the epilepsy population.^[@R42]^ In addition, the influence of recent ictal electrographic activity on neuropsychological performance could not be reliably evaluated (i.e., time from last seizure to testing) because people with TLE are often amnestic to their seizures and not all patients had seizures captured on video-EEG before testing.

The finding that patients with TLE are prone to mood and memory problems regardless of lesion status implies that different pathophysiologic abnormalities have common effects on behavioral function. We have previously shown that HS-TLE and MRI-neg TLE have distinct network abnormalities, implying that the epileptogenic mechanisms in these subtypes of TLE alter the topography of brain networks in unique ways.^[@R30]^ Yet, the current findings suggest that at the group level, the net effect on quantitative neuropsychological performance is indistinguishable. This gives rise to the tantalizing prospect for future investigation that neuropsychological impairments are the emergent property or final common outcome of diverse epileptogenic processes.
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